financetom
Business
financetom
/
Business
/
US FDA approves Bayer's menopause relief drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Bayer's menopause relief drug
Oct 24, 2025 11:02 AM

Oct 24 (Reuters) - Germany's Bayer said on

Friday the U.S. Food and Drug Administration has approved its

drug for menopause relief.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-US warned Nippon its US Steel bid poses a national security risk, sources say
Exclusive-US warned Nippon its US Steel bid poses a national security risk, sources say
Sep 6, 2024
WASHINGTON (Reuters) - The Biden administration told Nippon Steel in a letter on Saturday its $14.9 billion acquisition of U.S. Steel would pose a national security risk by harming the American steel industry, three people said, adding to evidence the U.S. is poised to block it. The deal faces opposition from numerous Democrats and Republicans, with Vice President and Democratic...
Nippon Steel shares up after news of US looking to block peer's acquisition
Nippon Steel shares up after news of US looking to block peer's acquisition
Sep 6, 2024
TOKYO (Reuters) - Shares of Nippon Steel climbed on Thursday, outperforming the wider Nikkei index, after the news that the White House was looking to block the company's $15 billion bid for its peer U.S. Steel. Sources told Reuters on Wednesday U.S. President Joe Biden was close to blocking Nippon Steel's takeover of U.S. Steel on national security risks, amid...
Vaxcyte to raise $1.3 bln from shares, warrants sale after stock's surge to record high
Vaxcyte to raise $1.3 bln from shares, warrants sale after stock's surge to record high
Sep 6, 2024
Sept 5 (Reuters) - Vaxcyte ( PCVX ), a clinical-stage vaccine developer, will raise $1.3 billion in gross proceeds by selling common stock and warrants, it said late on Wednesday, a day after its shares surged to a record high on promising results in a vaccine trial. The company said it would sell 10.2 million shares at $103 each and...
GM to launch its first ethanol-capable hybrid-flex vehicles in Brazil
GM to launch its first ethanol-capable hybrid-flex vehicles in Brazil
Sep 6, 2024
SAO PAULO (Reuters) - General Motors ( GM ) said on Wednesday that it would begin producing its first-ever hybrid-flex vehicles that can run on 100% ethanol or gasoline alongside their batteries in Brazil. Rival automakers Stellantis and Honda have also announced plans this year to launch hybrid-flex vehicles in the South American country, where most cars can run on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved